Related Experiment Video
Updated: Jun 9, 2026

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
Published on: October 28, 2015
Organic Semiconducting Polymers for Cancer Sonodynamic Immunotherapy
Peiting Hu1, Shasha He1, Huayu Tian1
1College of Chemistry and Chemical Engineering, Innovation Laboratory for Sciences and Technologies of Energy Materials of Fujian Province (IKKEM), State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Xiamen University, Xiamen 361005, China.
Organic semiconducting polymers offer a promising approach for cancer immunotherapy by enabling precise, ultrasound-triggered sonodynamic therapy (SDT). This strategy aims to overcome challenges like low tumor immunogenicity and toxicity for improved cancer treatment.
Area of Science:
- Biomedical Engineering
- Materials Science
- Immunology
Background:
- Cancer immunotherapy harnesses the patient's immune system but faces challenges like tumor microenvironments and toxicity.
- Activatable immunotherapies offer precise immune agent activation via specific signals.
- Ultrasound-triggered sonodynamic therapy (SDT) is a non-invasive modality with deep tissue penetration and spatiotemporal control.
Purpose of the Study:
- To review recent advances in using organic semiconducting polymers (SPs) for cancer immunotherapy.
- To discuss the challenges associated with SP-based SDT in cancer treatment.
- To explore future directions for developing precise and low-toxicity SP-based therapeutic strategies.
Main Methods:
- Focuses on organic semiconducting polymers (SPs) as sonosensitizers for SDT.
- Highlights the acoustic responsiveness, biocompatibility, and tunability of SPs.
- Reviews current literature on SP applications in ultrasound-triggered cancer immunotherapy.
Main Results:
- Organic SPs show potential as effective sonosensitizers for targeted SDT.
- SPs offer tunable properties for optimizing acoustic responsiveness and biocompatibility.
- This approach facilitates precise activation of immune responses within the tumor microenvironment.
Conclusions:
- Organic semiconducting polymers are promising candidates for advanced cancer immunotherapy via SDT.
- Further research is needed to address challenges and optimize SP-based SDT for clinical translation.
- Future strategies aim for enhanced precision and reduced systemic toxicity in cancer treatment.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

